Drug major Sun Pharmaceutical Industries on Monday said its Netherlands-based arm has fully acquired PJSC Biosintez, Russia by purchasing 3.04 per cent stake in the company under the mandatory tender offer.
Read more : https://www.indianweb2.com/2019/09/09/sun-pharma-arm-acquires-remaining-3-04-stake-pjsc-biosintez-russia/

Strides acquires the only FDA-approved integrated soft gel capsule manufacturing facility in the US, owned by Micelle, to support its operations in India.
Read more : https://www.in-pharmatechnologist.com/Article/2019/09/03/Strides-acquires-Micelle-facility-in-Florida

Swedish Orphan Biovitrum (Sobi) said it will snap up all outstanding shares of Dova for $27.50 per share in cash. The offer was sweetened with the promise of a non-tradeable Contingent Value Right that entitles shareholders to an additional $1.50 per share in cash upon regulatory approval of Doptelet (avatrombopag) for the treatment of chemotherapy-induced thrombocytopenia.
Read more : https://www.pharmalive.com/swedens-sobi-to-acquire-dova-pharmaceuticals-in-915-million-deal/